Showing results (1631-1640 of 2,996) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|May 7, 2002
Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factorBrigitte M Neugebauer, Christine Goy, Irmhild Budek, et al.Seminars in Thrombosis and Hemostasis|May 7, 2002
Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journeyEmmanuel J FavaloroSeminars in Thrombosis and Hemostasis|May 7, 2002
Successful treatment of patients with von Willebrand disease using a high-purity double-virus inactivated factor VIII/von Willebrand factor concentrate (Immunate)Günter Auerswald, Bruno Eberspächer, Werner Engl, et al.Seminars in Thrombosis and Hemostasis|May 7, 2002
Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand diseaseHans Peter Schwarz, Uwe Schlokat, Artur Mitterer, et al.Seminars in Thrombosis and Hemostasis|August 5, 2000
Phage display technology: a tool to explore the diversity of inhibitors to blood coagulation factor VIIIJ Voorberg, E N van den BrinkSeminars in Thrombosis and Hemostasis|August 5, 2000
Factor VIII Inhibitors. Natural autoantibodies and anti-idiotypesJ G Gilles, B Vanzieleghem, J M Saint-RemySeminars in Thrombosis and Hemostasis|August 5, 2000
Correlation between factor VIII genotype and inhibitor development in hemophilia AS S Fakharzadeh, H H KazazianSeminars in Thrombosis and Hemostasis|September 30, 2000
An update on heparins at the beginning of the new millenniumJ Fareed, D A Hoppensteadt, R L BickSeminars in Thrombosis and Hemostasis|September 30, 2000
Comparative pharmacokinetics of LMWHsM M Samama, G T GerotziafasSeminars in Thrombosis and Hemostasis|September 30, 2000
Prophylaxis and treatment of deep-vein thrombosisH K BreddinPageof 300